Icon

PROGRAF (nda050708)- (EQ 1MG BASE,EQ 5MG BASE,EQ 0.5MG BASE)

TACROLIMUS ASTELLAS
EQ 1MG BASE,EQ 5MG BASE,EQ 0.5MG BASE
No No
Expired Expired
2013-Mar-29 None
None No
PROGRAF is a calcineurin-inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in adult and pediatric patients receiving allogeneic liver, kidney, heart, or lung transplants, in combination with other immunosuppressants.
12 0 11
Total Other Developers 16
Drugs with Suitability No
EQ 1MG BASE ** ** Up - 9
EQ 5MG BASE ** ** - - 9
EQ 0.5MG BASE ** ** Up - 8
NDA Sales Available Total Generic Sales Available
Yes 10
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ****** ******* ******* *********** **** **. *-*/* *** *-*, *** ********** **** ***** *****, ******* *****, **** ******, *********** ******, ***** (***) ***
****** ** ****** **** *** **. *****'* ************ ******* *********** ****** **. **, ** ****, ** **** & ** ****, ********** ******* *** ******, *******-********** ********,, *******-**********, ********* ******, ***** (***) ***
****** ***** **** ** ***. *********** ** *** ****** **** ********** ****, *** **, ******, ****** **** (**) *****, ****** ****** (***) ***
****** ******* ****** ******* ****** ******* ******* *********** ** **/*,******************, ********* *****, ****** *****, *********, ********* ******, ***** (***) ***
****** ******* ******* ****** ****** ******* *********** ****** *****, ******, *****, *****, ******** ******* ******, ***** (***) ***
****** ***** **** *** ***** ************ ******* *********** ****** ** ****, ****, ****, **** ******* *****, ****** ********, *****, ******** ******* ******, ***** (***) ***
****** ******* ******* ***************, *** *********** **** ***** ***** ** *** ***, *****, ******* (**) *****, ****** ****** (***) ***
****** ******** ****** *** ******** *************** ******* *********** **** **. *, *****-*, ****** **** *** *********, ****, ****** ******* ******, ***** (***) ***
****** ****** ****** ****** ******* *** *********** ******* ******** ****, **** **. *, *, * & *, ***** **, ***********-****** **** ****, *********** ****, *********, ********* ******, ***** (***) ***
****** ****** ****** ****** ****** ******* *********** ******* ******** ****, ***** **, **** **.*, ***** **, *********** - ****** **** ****, *********** ****, *********, ********* ******, ***** (***) ***
****** ******* ******* *** ******* ******* ******* *********** **** - **, ***-*** / ** ** ******** **. ******, *********, ******* ******, ***** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. ***/***-****** / **** **.***/****-*********** , *******-***** ******* , ****** -******, ******, *********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.